Influenza Resistance Information Study

Completed

Conditions studied: Influenza

In brief

This study will assist in the early detection of influenza resistant to antivirals and will monitor the clinical outcome of adults and children infected with influenza according to subtype and susceptibility. Participants clinically diagnosed with influenza will undergo a rapid diagnostic test and viral sampling at Baseline and on Days 3, 6, and 10. Participants will be clinically managed according to local guidelines and the decision to treat/not treat will be at the discretion of the Investigator.

Key facts

Study ID

NCT00884117

Run by

Hoffmann-La Roche

People needed

4561

Starts

2009-01-01

Expected to finish

2015-11-01

Last updated by the study team

2016-10-19

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants greater than or equal to (≥) 1 year of age with a positive diagnostic test of influenza and/or displaying symptoms suggestive of influenza-like illness (during Years 1 to 5)
• Participants less than or equal to (≤) 12 years of age with a positive diagnostic test of influenza and displaying symptoms suggestive of influenza-like illness and who are being or, according to local standard of care, will be treated with an influenza antiviral (during Years 6 and 7)

You may not qualify if…

• Allergy to any potential influenza therapy
• Living in the same household or residential/care home as another study participant

Where it is running

• Study site — Chicago, Illinois, United States
• Study site — Westmead, New South Wales, Australia
• Study site — Bron, France
• Study site — Berlin, Germany
• Study site — Shatin, Hong Kong
• Study site — Rotterdam, Netherlands
• Study site — Sandnes, Norway
• Study site — Krakow, Poland

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.